Back to results
US 11,697,678 B2Granted
Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
AssigneesPfizer Inc., Inserm (Institut National De La Sante Et De La Recherche Medicale), Université CôTe D'Azur
InventorsElvire Gouze, Stéphanie Garcia
Life of this patent
Estimating the term…
Abstract
The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth regardation disorders, such as achondroplasia.
Claims19
A polynucleotide encoding a soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptide comprising the amino acid sequence of SEQ ID NO:
- 33.
Dependencies are inferred from the claim text.